USANA Health Sciences, Inc. (NYSE:USNA) CFO G Doug Iiekking Sells 4,548 Shares

USANA Health Sciences, Inc. (NYSE:USNA) CFO G Doug Iiekking sold 4,548 shares of the firm’s stock in a transaction on Friday, May 9th. The stock was sold at an average price of $29.61, for a total transaction of $134,666.28. The sale was disclosed in a legal filing with the SEC, which is available through this link.

USANA Health Sciences Trading Down 1.8%

Shares of USNA stock opened at $29.20 on Thursday. The stock has a 50 day simple moving average of $27.20 and a 200-day simple moving average of $32.56. The company has a market cap of $543.79 million, a price-to-earnings ratio of 10.32, a price-to-earnings-growth ratio of 0.93 and a beta of 0.60. USANA Health Sciences, Inc. has a 12-month low of $23.10 and a 12-month high of $49.78.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings data on Tuesday, April 22nd. The company reported $0.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.70 by $0.03. The firm had revenue of $249.54 million during the quarter, compared to analysts’ expectations of $243.08 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. During the same quarter in the prior year, the business posted $0.86 earnings per share. On average, equities analysts forecast that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on USNA. Sidoti lowered USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 18th. StockNews.com downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 14th. Finally, DA Davidson reduced their target price on shares of USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating for the company in a research note on Thursday, February 27th.

Institutional Trading of USANA Health Sciences

A number of institutional investors have recently added to or reduced their stakes in USNA. Barclays PLC grew its holdings in shares of USANA Health Sciences by 111.9% in the 3rd quarter. Barclays PLC now owns 27,737 shares of the company’s stock worth $1,052,000 after acquiring an additional 14,647 shares during the period. Franklin Resources Inc. raised its stake in shares of USANA Health Sciences by 9.2% during the 3rd quarter. Franklin Resources Inc. now owns 21,050 shares of the company’s stock worth $750,000 after buying an additional 1,771 shares during the last quarter. Nordea Investment Management AB boosted its position in shares of USANA Health Sciences by 5.7% in the 4th quarter. Nordea Investment Management AB now owns 50,450 shares of the company’s stock worth $1,814,000 after buying an additional 2,723 shares in the last quarter. Exchange Traded Concepts LLC grew its stake in USANA Health Sciences by 11.3% in the 4th quarter. Exchange Traded Concepts LLC now owns 8,578 shares of the company’s stock valued at $308,000 after acquiring an additional 869 shares during the last quarter. Finally, Pacer Advisors Inc. increased its holdings in USANA Health Sciences by 8.8% during the 4th quarter. Pacer Advisors Inc. now owns 592,001 shares of the company’s stock valued at $21,247,000 after acquiring an additional 47,745 shares in the last quarter. Hedge funds and other institutional investors own 54.25% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.